It also reduces endothelial dysfunction by downregulating the protein kinase C-β/nicotinamide adenine dinucleotide phosphate (PKC-β/NADPH) and NF-κB/inducible nitric oxide synthase (iNOS) pathways [22]. The gene discussed is NFKB1; the disease is endothelial dysfunction.